Company
COUR Pharmaceutical Development Company, Inc.
COUR Pharmaceutical Development Company, Inc. has 1 drug tracked on RxWires: 1 in Phase 1/2.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| CNP-103 | Phase 1/2 | Type 1 Diabetes Mellitus |
Latest
No recent events.
Follow COUR Pharmaceutical Development Company, Inc. on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.